[go: up one dir, main page]

Cordes, 2020 - Google Patents

Targeted gene transfer to enhance safety and efficacy of immunotherapy

Cordes, 2020

View PDF
Document ID
7137775925953463977
Author
Cordes N
Publication year

External Links

Snippet

The remarkable success of chimeric antigen receptor (CAR) T cell therapy in phase I/II trials resulted in market approval for the treatment of specific B cell malignancies. However, a considerable number of relapses were reported, for instance due to impaired T cell …
Continue reading at freidok.uni-freiburg.de (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse Transcribing RNA Viruses
    • C12N2740/00011Reverse Transcribing RNA Viruses
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2810/00Vectors comprising a targeting moiety
    • C12N2810/50Vectors comprising as targeting moiety peptide derived from defined protein
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Hamilton et al. In vivo human T cell engineering with enveloped delivery vehicles
JP7216045B2 (en) Central memory T cells for adoptive T cell therapy
US12258574B2 (en) Methods and compositions for transducing lymphocytes and regulating the activity thereof
CN111479921B (en) Methods and compositions for genetically modifying and expanding lymphocytes and modulating their activity
Moffett et al. Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers
AU2018226884A1 (en) Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof
US20230407330A1 (en) Vector system for delivery of multiple polynucleotides and uses thereof
AU2017292936A1 (en) Methods and compositions for transducing lymphocytes and regulating the activity thereof
IL253399B2 (en) Modified hepatitis post-transcriptional regulatory element polynucleotides, compositions containing same and uses thereof
JP2021500909A (en) Adapter-based retroviral vector system for selective transduction of target cells
CN117642420A (en) Lipid particles containing truncated baboon endogenous retrovirus (BaEV) envelope glycoproteins and related methods and uses
US20200397821A1 (en) Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof
US20230392139A1 (en) Methods and compositions for transducing and expanding lymphocytes and regulating the activity thereof
US20230398148A1 (en) Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily chain locus and related polynucleotides and methods
Cordes Targeted gene transfer to enhance safety and efficacy of immunotherapy
WO2024044557A1 (en) Compositions and methods for targeted delivery of crispr-cas effector polypeptides
Winter et al. A novel pseudotype derived of the canine distemper virus for adapter-mediated lentiviral transduction in vivo
WO2025184529A1 (en) Viral particles with fusogen display and related compositions and methods
WO2024119157A1 (en) Lipid particles with cofusogens and methods of producing and using the same
Fichter Development of Novel Transient Delivery Systems for Gene Therapy
US20220315894A1 (en) Method for Transduction of T Cells in the Presence of Malignant Cells
WO2024243340A1 (en) Tandem fusogens and related lipid particles
WO2024220560A1 (en) Engineered protein g fusogens and related lipid particles and methods thereof
CN119677772A (en) Engineered stem cells and their uses
HK1247046B (en) Central memory t cells for adoptive t cell therapy